InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study

INTRODUCTION: The key role of microRNAs (miRNAs) in the pathogenesis of psoriasis has been extensively discussed in the literature. Increasing evidence suggests that the analysis of miRNA levels may constitute an innovative approach for exploring the clinical efficacy of anti-inflammatory therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Diotallevi, Federico, Matacchione, Giulia, d’Agostino, Giovanni Marco, Gioacchini, Helena, Campanati, Anna, Sabbatinelli, Jacopo, Olivieri, Fabiola, Offidani, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264314/
https://www.ncbi.nlm.nih.gov/pubmed/37198526
http://dx.doi.org/10.1007/s13555-023-00931-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264314/
https://www.ncbi.nlm.nih.gov/pubmed/37198526
http://dx.doi.org/10.1007/s13555-023-00931-1

Ejemplares similares